Best Practices for Preventing CAPA-Related Audit Findings
Best Practices for Preventing CAPA-Related Audit Findings How to Prevent CAPA-Related Audit Findings in Clinical Trials Introduction: Why CAPA Failures Remain a Common Audit Finding Corrective and Preventive Action (CAPA) systems form the backbone of quality assurance in clinical trials. Regulators such as the FDA, EMA, and MHRA expect sponsors, CROs, and investigator sites to…
Read More “Best Practices for Preventing CAPA-Related Audit Findings” »